We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 582

House IP Subcommittee Slams "Reprehensible" EDTX
  • Oblon
  • USA
  • July 14 2017

Judge Gilstrap Singled Out in Congressional Hearing as Defying SCOTUS Yesterday, the House IP Subcommittee on the Courts, Intellectual Property and


CAFC Finds Forfeit of Half-Win Before PTAB
  • Oblon
  • USA
  • July 18 2017

PTAB practitioners must always be mindful of the Board's longstanding practice to treat grouped claims as standing or falling together. That is


A Post-Grant Lesson for Patent Prosecutors
  • Oblon
  • USA
  • June 19 2017

Every so often a decision comes out of the USPTO's Patent Trial & Appeal Board (PTAB) or the Federal Circuit that has immediate value for patent


Constitutional Challenges to PTAB Another Dead End
  • Oblon
  • USA
  • May 18 2017

Over the years the constitutionality of USPTO post-grant procedures have been repeatedly challenged. Typically, it is argued that the 7th Amendment's


Another WiFi One Hint from the CAFC
  • Oblon
  • USA
  • June 21 2017

The en banc opinion on the scope of the AIA's appeal bar (35 U.S.C. 324(e)314(d)) remains outstanding in WiFi One. Still, we have seen a few


Patent reissue oath practice revised by USPTO
  • Oblon
  • USA
  • January 11 2012

As anyone that has ever filed a patent reissue can attest, the inconsistent application of oath requirements can be maddening


PTAB update & public comments
  • Oblon
  • USA
  • November 19 2015

Yesterday marked the close of the public comment period for both the Comments on a Proposed Pilot Program Exploring an Alternative Approach to


CBM patent need not be directed to financial sector
  • Oblon
  • USA
  • July 10 2015

Yesterday, the CAFC issued its long awaited decision in the dispute between Versata and SAP (here). The appeal stemmed from the very first Covered


AIA Trials Unconstitutional? Don't Bet on It
  • Oblon
  • USA
  • June 13 2017

The Supreme Court has had at least three occasions over the past 7 months to review the constitutionality of AIA trial proceedings it declined all


Biosimilar Strategy Leverages PTAB
  • Oblon
  • USA
  • May 18 2016

As discussed previously, biosimilar applicants can gain significant strategic advantage by availing themselves of Patent Trial & Appeal Board (PTAB